Resection of pulmonary metastases from primary bone and soft tissue tumors

Research output: Contribution to journalArticle

Abstract

An aggressive approach to surgical resection of pulmonary metastases of bone and soft tissue sarcomas seems to extend patient survival. This therapy is most applicable to pulmonary metastases but can be considered for metastases in other sites. Criteria for appropriate selection of these patients has been outlined. However, no prospective randomized trial of surgery versus alternative therapy for these lesions has been performed. Thus, it remains unproven in a controlled clinical test that metastasectomy is beneficial. Nevertheless, there is a well-defined group of long-term survivors who are disease-free following metastasectomy. Because alternative therapy does not yield this benefit, resection of metastases in appropriately selected sarcoma patients seems warranted.

Original languageEnglish (US)
Pages (from-to)247-250
Number of pages4
JournalSeminars in Orthopaedics
Volume6
Issue number4
StatePublished - 1991

Fingerprint

Metastasectomy
Neoplasm Metastasis
Bone and Bones
Lung
Complementary Therapies
Sarcoma
Patient Selection
Neoplasms
Survivors
Survival
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Resection of pulmonary metastases from primary bone and soft tissue tumors. / Goodnight Jr, James E.

In: Seminars in Orthopaedics, Vol. 6, No. 4, 1991, p. 247-250.

Research output: Contribution to journalArticle

@article{bbf9fcbacd6849b4ab88ae98b499be22,
title = "Resection of pulmonary metastases from primary bone and soft tissue tumors",
abstract = "An aggressive approach to surgical resection of pulmonary metastases of bone and soft tissue sarcomas seems to extend patient survival. This therapy is most applicable to pulmonary metastases but can be considered for metastases in other sites. Criteria for appropriate selection of these patients has been outlined. However, no prospective randomized trial of surgery versus alternative therapy for these lesions has been performed. Thus, it remains unproven in a controlled clinical test that metastasectomy is beneficial. Nevertheless, there is a well-defined group of long-term survivors who are disease-free following metastasectomy. Because alternative therapy does not yield this benefit, resection of metastases in appropriately selected sarcoma patients seems warranted.",
author = "{Goodnight Jr}, {James E}",
year = "1991",
language = "English (US)",
volume = "6",
pages = "247--250",
journal = "Seminars in Orthopaedics",
issn = "0882-052X",
number = "4",

}

TY - JOUR

T1 - Resection of pulmonary metastases from primary bone and soft tissue tumors

AU - Goodnight Jr, James E

PY - 1991

Y1 - 1991

N2 - An aggressive approach to surgical resection of pulmonary metastases of bone and soft tissue sarcomas seems to extend patient survival. This therapy is most applicable to pulmonary metastases but can be considered for metastases in other sites. Criteria for appropriate selection of these patients has been outlined. However, no prospective randomized trial of surgery versus alternative therapy for these lesions has been performed. Thus, it remains unproven in a controlled clinical test that metastasectomy is beneficial. Nevertheless, there is a well-defined group of long-term survivors who are disease-free following metastasectomy. Because alternative therapy does not yield this benefit, resection of metastases in appropriately selected sarcoma patients seems warranted.

AB - An aggressive approach to surgical resection of pulmonary metastases of bone and soft tissue sarcomas seems to extend patient survival. This therapy is most applicable to pulmonary metastases but can be considered for metastases in other sites. Criteria for appropriate selection of these patients has been outlined. However, no prospective randomized trial of surgery versus alternative therapy for these lesions has been performed. Thus, it remains unproven in a controlled clinical test that metastasectomy is beneficial. Nevertheless, there is a well-defined group of long-term survivors who are disease-free following metastasectomy. Because alternative therapy does not yield this benefit, resection of metastases in appropriately selected sarcoma patients seems warranted.

UR - http://www.scopus.com/inward/record.url?scp=0026388956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026388956&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026388956

VL - 6

SP - 247

EP - 250

JO - Seminars in Orthopaedics

JF - Seminars in Orthopaedics

SN - 0882-052X

IS - 4

ER -